414 related articles for article (PubMed ID: 32655701)
1. Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.
Sun J; Zhao T; Zhao D; Qi X; Bao X; Shi R; Su C
Ther Adv Med Oncol; 2020; 12():1758835920937904. PubMed ID: 32655701
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
Shi R; Bao X; Unger K; Sun J; Lu S; Manapov F; Wang X; Belka C; Li M
Theranostics; 2021; 11(10):5061-5076. PubMed ID: 33754044
[No Abstract] [Full Text] [Related]
3. Establishment and evaluation of module-based immune-associated gene signature to predict overall survival in patients of colon adenocarcinoma.
Lu J; Annunziata F; Sirvinskas D; Omrani O; Li H; Rasa SMM; Krepelova A; Adam L; Neri F
J Biomed Sci; 2022 Oct; 29(1):81. PubMed ID: 36229806
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
5. A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis.
Wang Y; Zhang Q; Gao Z; Xin S; Zhao Y; Zhang K; Shi R; Bao X
Cancer Cell Int; 2019; 19():100. PubMed ID: 31015800
[TBL] [Abstract][Full Text] [Related]
6. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic nomogram for patients with lung adenocarcinoma based on a novel 6-DNA repair-related gene signature.
Chen M; Dong H; Deng S; Zhou Y
Am J Transl Res; 2021; 13(4):1952-1970. PubMed ID: 34017369
[TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of a Gene Signature-Based Prognostic Model to Improve Survival Prediction in Adrenocortical Carcinoma Patients.
Ge X; Liu Z; Jiao X; Yin X; Wang X; Li G
Int J Endocrinol; 2021; 2021():2077633. PubMed ID: 34858497
[TBL] [Abstract][Full Text] [Related]
9. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Li W; Liu S; Su S; Chen Y; Sun G
PeerJ; 2021; 9():e10470. PubMed ID: 33510968
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma.
Wang C; Gu X; Zhang X; Zhou M; Chen Y
Front Oncol; 2021; 11():756096. PubMed ID: 34745990
[TBL] [Abstract][Full Text] [Related]
13. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma.
Zhang W; Lyu P; Andreev D; Jia Y; Zhang F; Bozec A
Front Cell Dev Biol; 2022; 10():974851. PubMed ID: 36578780
[No Abstract] [Full Text] [Related]
15. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
16. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
Jin D; Song Y; Chen Y; Zhang P
Biomed Res Int; 2020; 2020():7929132. PubMed ID: 32596372
[TBL] [Abstract][Full Text] [Related]
18. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
19. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Xu Q; Chen Y
Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
[TBL] [Abstract][Full Text] [Related]
20. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
